{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T04:45:48Z","timestamp":1777178748639,"version":"3.51.4"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:00:00Z","timestamp":1669248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009109","name":"Bayer Pharma AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005075","name":"University Medical Centre Groningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005075","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Colloid and Interface Science"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jcis.2022.11.124","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T15:42:36Z","timestamp":1669304556000},"page":"383-395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Microfluidic preparation and optimization of sorafenib-loaded poly(ethylene glycol-block-caprolactone) nanoparticles for cancer therapy applications"],"prefix":"10.1016","volume":"633","author":[{"given":"Voitto","family":"K\u00e4nk\u00e4nen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micaela","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zehua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jani","family":"Seitsonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sami-Pekka","family":"Hirvonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janne","family":"Ruokolainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o F.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jouni","family":"Hirvonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vimalkumar","family":"Balasubramanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9lder A.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.jcis.2022.11.124_b0005","doi-asserted-by":"crossref","first-page":"5969","DOI":"10.1039\/c2cs35115c","article-title":"Self-assembly of block copolymers","volume":"41","author":"Mai","year":"2012","journal-title":"Chem. Soc. Rev."},{"issue":"7","key":"10.1016\/j.jcis.2022.11.124_b0010","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/jps.10397","article-title":"Amphiphilic block copolymers for drug delivery","volume":"92","author":"Adams","year":"2003","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.jcis.2022.11.124_b0015","first-page":"482","article-title":"Strategies to enhance solubility and dissolution of a poorly water soluble drug","volume":"2","author":"Bharti","year":"2015","journal-title":"J. Innovations in Pharmaceuticals and Biol. Sci."},{"issue":"4","key":"10.1016\/j.jcis.2022.11.124_b0020","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/jnci\/90.4.300","article-title":"Complement Activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study","volume":"90","author":"Szebeni","year":"1998","journal-title":"JNCI: J. National Cancer Institute"},{"issue":"3","key":"10.1016\/j.jcis.2022.11.124_b0025","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jconrel.2013.09.026","article-title":"Mind the gap: a survey of how cancer drug carriers are susceptible to the gap between research and practice","volume":"172","author":"Stirland","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jcis.2022.11.124_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.601626","article-title":"Biodegradable polymeric nanoparticles for drug delivery to solid tumors","volume":"12","author":"Gagliardi","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.jcis.2022.11.124_b0035","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.addr.2012.08.012","article-title":"Polymer therapeutics-prospects for 21st century: the end of the beginning","volume":"65","author":"Duncan","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jcis.2022.11.124_b0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2015.01.002","article-title":"Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity","volume":"91","author":"Maeda","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12 Part 1","key":"10.1016\/j.jcis.2022.11.124_b0045","first-page":"6387","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.jcis.2022.11.124_b0050","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00432-014-1767-3","article-title":"Cancer active targeting by nanoparticles: a comprehensive review of literature","volume":"141","author":"Bazak","year":"2015","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.jcis.2022.11.124_b0055","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.imlet.2017.07.015","article-title":"Nanoparticles and targeted drug delivery in cancer therapy","volume":"190","author":"Bahrami","year":"2017","journal-title":"Immunol. Lett."},{"issue":"10","key":"10.1016\/j.jcis.2022.11.124_b0060","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.progpolymsci.2010.04.002","article-title":"The return of a forgotten polymer\u2014Polycaprolactone in the 21st century","volume":"35","author":"Woodruff","year":"2010","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.jcis.2022.11.124_b0065","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2147\/CCID.S229054","article-title":"F., Polycaprolactone: or how a well-known and futuristic polymer has become an innovative collagen-stimulator in esthetics","volume":"13","author":"Christen","year":"2020","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"issue":"7","key":"10.1016\/j.jcis.2022.11.124_b0070","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s11095-013-1067-7","article-title":"The immunogenicity of polyethylene glycol: facts and fiction","volume":"30","author":"Schellekens","year":"2013","journal-title":"Pharm. Res."},{"issue":"6","key":"10.1016\/j.jcis.2022.11.124_b0075","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jsps.2017.04.001","article-title":"Toxicity evaluation of methoxy poly(ethylene oxide)-block-poly(\u03b5-caprolactone) polymeric micelles following multiple oral and intraperitoneal administration to rats","volume":"25","author":"Binkhathlan","year":"2017","journal-title":"Saudi Pharmaceutical J."},{"key":"10.1016\/j.jcis.2022.11.124_b0080","doi-asserted-by":"crossref","unstructured":"R.P, Bulc\u00e3o, et al., Acute and Subchronic Toxicity Evaluation of Poly(\u025b-Caprolactone) Lipid-Core Nanocapsules in Rats. Toxicological Sciences, 2013. 132(1): p. 162-176.","DOI":"10.1093\/toxsci\/kfs334"},{"issue":"1","key":"10.1016\/j.jcis.2022.11.124_b0085","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/jbm.b.31370","article-title":"Acute toxicity evaluation of biodegradable in situ gel-forming controlled drug delivery system based on thermosensitive PEG-PCL-PEG hydrogel","volume":"91B","author":"Gong","year":"2009","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"issue":"15","key":"10.1016\/j.jcis.2022.11.124_b0090","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0142-9612(95)93577-Z","article-title":"Monocryl suture, a new ultra-pliable absorbable monofilament suture","volume":"16","author":"Bezwada","year":"1995","journal-title":"Biomaterials"},{"issue":"16","key":"10.1016\/j.jcis.2022.11.124_b0095","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1039\/b907628j","article-title":"On the mechanism of formation of vesicles from poly(ethylene oxide)-block-poly(caprolactone) copolymers","volume":"5","author":"Adams","year":"2009","journal-title":"Soft Matter"},{"issue":"29","key":"10.1016\/j.jcis.2022.11.124_b0100","doi-asserted-by":"crossref","first-page":"17997","DOI":"10.1039\/C7RA01959A","article-title":"Polymeric vesicle formation via temperature-assisted nanoprecipitation","volume":"7","author":"Zhou","year":"2017","journal-title":"RSC Adv."},{"issue":"6","key":"10.1016\/j.jcis.2022.11.124_b0105","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/marc.200700795","article-title":"Regulation of micellar morphology of PCL-b-PEO block copolymers by crystallization temperature","volume":"29","author":"Du","year":"2008","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.jcis.2022.11.124_b0110","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jbiotec.2015.09.034","article-title":"Nanobody-functionalized PEG-b-PCL polymersomes and their targeting study","volume":"214","author":"Zou","year":"2015","journal-title":"J. Biotechnol."},{"issue":"4","key":"10.1016\/j.jcis.2022.11.124_b0115","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nnano.2007.70","article-title":"Shape effects of filaments versus spherical particles in flow and drug delivery","volume":"2","author":"Geng","year":"2007","journal-title":"Nat. Nanotechnol."},{"issue":"8","key":"10.1016\/j.jcis.2022.11.124_b0120","doi-asserted-by":"crossref","first-page":"1800068","DOI":"10.1002\/adtp.201800068","article-title":"Adaptive polymersome and micelle morphologies in anticancer nanomedicine: from design rationale to fabrication and proof-of-concept studies","volume":"1","author":"Pijpers","year":"2018","journal-title":"Advanced Therapeutics"},{"issue":"9","key":"10.1016\/j.jcis.2022.11.124_b0125","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1021\/acs.iecr.9b04747","article-title":"Formulation of nanoparticles using mixing-induced nanoprecipitation for drug delivery","volume":"59","author":"Liu","year":"2020","journal-title":"Ind. Eng. Chem. Res."},{"issue":"1","key":"10.1016\/j.jcis.2022.11.124_b0130","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijpharm.2017.08.064","article-title":"Nanoprecipitation process: from encapsulation to drug delivery","volume":"532","author":"Mart\u00ednez Rivas","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jcis.2022.11.124_b0135","doi-asserted-by":"crossref","first-page":"1904673","DOI":"10.1002\/smll.201904673","article-title":"Microfluidics for production of particles: mechanism, methodology, and applications","volume":"16","author":"Liu","year":"2020","journal-title":"Small"},{"issue":"10","key":"10.1016\/j.jcis.2022.11.124_b0140","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nnano.2012.168","article-title":"Microfluidic technologies for accelerating the clinical translation of nanoparticles","volume":"7","author":"Valencia","year":"2012","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.jcis.2022.11.124_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10404-009-0421-x","article-title":"Micro-injection moulding of polymer microfluidic devices","volume":"7","author":"Attia","year":"2009","journal-title":"Microfluid. Nanofluid."},{"issue":"1-2","key":"10.1016\/j.jcis.2022.11.124_b0150","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ijpharm.2016.11.024","article-title":"Microfluidics platform for glass capillaries and its application in droplet and nanoparticle fabrication","volume":"516","author":"Herranz-Blanco","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"7101","key":"10.1016\/j.jcis.2022.11.124_b0155","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nature05058","article-title":"The origins and the future of microfluidics","volume":"442","author":"Whitesides","year":"2006","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.jcis.2022.11.124_b0160","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/adfm.201404122","article-title":"On-chip self-assembly of a smart hybrid nanocomposite for antitumoral applications","volume":"25","author":"Herranz-Blanco","year":"2015","journal-title":"Adv. Funct. Mater."},{"issue":"9","key":"10.1016\/j.jcis.2022.11.124_b0165","doi-asserted-by":"crossref","first-page":"1604508","DOI":"10.1002\/adfm.201604508","article-title":"A Nano-in-nano vector: merging the best of polymeric nanoparticles and drug nanocrystals","volume":"27","author":"Liu","year":"2017","journal-title":"Adv. Funct. Mater."},{"issue":"14","key":"10.1016\/j.jcis.2022.11.124_b0170","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1002\/adma.201405408","article-title":"A Versatile and robust microfluidic platform toward high throughput synthesis of homogeneous nanoparticles with tunable properties","volume":"27","author":"Liu","year":"2015","journal-title":"Adv. Mater."},{"issue":"2","key":"10.1016\/j.jcis.2022.11.124_b0175","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1021\/acs.nanolett.6b03251","article-title":"Core\/shell nanocomposites produced by superfast sequential microfluidic nanoprecipitation","volume":"17","author":"Liu","year":"2017","journal-title":"Nano Lett."},{"key":"10.1016\/j.jcis.2022.11.124_b0180","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.actbio.2020.12.024","article-title":"Preparation of cetyl palmitate-based PEGylated solid lipid nanoparticles by microfluidic technique","volume":"121","author":"Arduino","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jcis.2022.11.124_b0185","unstructured":"EMA, European public assessment report (EPAR) for Nexavar - Annex 1 - Summary of product characteristics. 2021."},{"key":"10.1016\/j.jcis.2022.11.124_b0190","doi-asserted-by":"crossref","unstructured":"S.M, Wilhelm, et al., BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF\/MEK\/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis. Cancer Research, 2004. 64(19): p. 7099.","DOI":"10.1158\/0008-5472.CAN-04-1443"},{"key":"10.1016\/j.jcis.2022.11.124_b0195","doi-asserted-by":"crossref","unstructured":"E, Galanis, et al., Phase II Study of Bevacizumab in Combination with Sorafenib in Recurrent Glioblastoma (N0776): A North Central Cancer Treatment Group Trial. Clin Cancer Res, 2013. 19(17): p. 4816.","DOI":"10.1158\/1078-0432.CCR-13-0708"},{"issue":"3","key":"10.1016\/j.jcis.2022.11.124_b0200","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neulet.2010.05.009","article-title":"Sorafenib exerts anti-glioma activity in vitro and in vivo","volume":"478","author":"Siegelin","year":"2010","journal-title":"Neurosci. Lett."},{"issue":"15","key":"10.1016\/j.jcis.2022.11.124_b0205","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1002\/cncr.25275","article-title":"Concurrent radiotherapy and temozolomide followed by temozolomide and sorafenib in the first-line treatment of patients with glioblastoma multiforme","volume":"116","author":"Hainsworth","year":"2010","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.jcis.2022.11.124_b0210","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/14656566.2017.1309024","article-title":"Sorafenib for the treatment of breast cancer","volume":"18","author":"Bronte","year":"2017","journal-title":"Expert Opin. Pharmacother."},{"issue":"3","key":"10.1016\/j.jcis.2022.11.124_b0215","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/bjc.2012.287","article-title":"Sorafenib in advanced melanoma: a critical role for pharmacokinetics?","volume":"107","author":"Pecuchet","year":"2012","journal-title":"Br. J. Cancer"},{"issue":"12","key":"10.1016\/j.jcis.2022.11.124_b0220","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1097\/JTO.0000000000000693","volume":"10","author":"Paz-Ares","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.jcis.2022.11.124_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120346","article-title":"LinTT1 peptide-functionalized liposomes for targeted breast cancer therapy","volume":"597","author":"d'Avanzo","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jcis.2022.11.124_b0230","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijpharm.2019.03.008","article-title":"Preparation of cubic-shaped sorafenib-loaded nanocomposite using well-defined poly(vinyl alcohol alt-propenylene) copolymer","volume":"562","author":"Feczk\u00f3","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.jcis.2022.11.124_b0235","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.nano.2016.01.017","article-title":"iRGD decorated lipid-polymer hybrid nanoparticles for targeted co-delivery of doxorubicin and sorafenib to enhance anti-hepatocellular carcinoma efficacy","volume":"12","author":"Zhang","year":"2016","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"21","key":"10.1016\/j.jcis.2022.11.124_b0240","doi-asserted-by":"crossref","first-page":"6209","DOI":"10.7150\/thno.36283","article-title":"Mitochondrial membrane anchored photosensitive nano-device for lipid hydroperoxides burst and inducing ferroptosis to surmount therapy-resistant cancer","volume":"9","author":"Sang","year":"2019","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.jcis.2022.11.124_b0245","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1080\/10717544.2018.1507061","article-title":"Development and characterization of sorafenib-loaded lipid nanocapsules for the treatment of glioblastoma","volume":"25","author":"Clavreul","year":"2018","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.jcis.2022.11.124_b0250","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1080\/10717544.2019.1580797","article-title":"Dual-functionalized liposome by co-delivery of paclitaxel with sorafenib for synergistic antitumor efficacy and reversion of multidrug resistance","volume":"26","author":"Lei","year":"2019","journal-title":"Drug Deliv."},{"issue":"37","key":"10.1016\/j.jcis.2022.11.124_b0255","doi-asserted-by":"crossref","first-page":"12780","DOI":"10.1021\/ja053902e","article-title":"Hydrolytic Degradation of Poly(ethylene oxide)-block-Polycaprolactone Worm Micelles","volume":"127","author":"Geng","year":"2005","journal-title":"J. Am. Chem. Soc."},{"issue":"2-3","key":"10.1016\/j.jcis.2022.11.124_b0260","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0169-409X(95)00026-4","article-title":"The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres","volume":"16","author":"Gref","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3-4","key":"10.1016\/j.jcis.2022.11.124_b0265","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0927-7765(99)00156-3","article-title":"\u2018Stealth\u2019 corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption","volume":"18","author":"Gref","year":"2000","journal-title":"Colloids and Surfaces B-Biointerfaces"},{"issue":"5153","key":"10.1016\/j.jcis.2022.11.124_b0270","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1126\/science.8128245","article-title":"Biodegradable long-circulating polymeric nanospheres","volume":"263","author":"Gref","year":"1994","journal-title":"Science"},{"issue":"36","key":"10.1016\/j.jcis.2022.11.124_b0275","doi-asserted-by":"crossref","first-page":"2204666","DOI":"10.1002\/adfm.202204666","article-title":"Promoting cardiac repair through simple engineering of nanoparticles with exclusive targeting capability toward myocardial reperfusion injury by thermal resistant microfluidic platform","volume":"32","author":"Liu","year":"2022","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jcis.2022.11.124_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119900","article-title":"Evaluation of the effects of nanoprecipitation process parameters on the size and morphology of poly(ethylene oxide)-block-polycaprolactone nanostructures","volume":"590","author":"K\u00e4nk\u00e4nen","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.jcis.2022.11.124_b0285","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s13346-013-0129-z","article-title":"In vitro dissolution testing strategies for nanoparticulate drug delivery systems: recent developments and challenges","volume":"3","author":"Shen","year":"2013","journal-title":"Drug Deliv. Transl. Res."},{"issue":"20","key":"10.1016\/j.jcis.2022.11.124_b0290","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1016\/S0142-9612(03)00207-2","article-title":"Biodegradable poly(\u03b5-caprolactone)-poly(ethylene glycol) block copolymers: characterization and their use as drug carriers for a controlled delivery system","volume":"24","author":"Zhou","year":"2003","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.jcis.2022.11.124_b0295","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1140\/epje\/e2003-00002-5","article-title":"Control of amphiphilic block copolymer morphologies using solution conditions","volume":"10","author":"Choucair","year":"2003","journal-title":"Eur. Phys. J. E"},{"issue":"11","key":"10.1016\/j.jcis.2022.11.124_b0300","doi-asserted-by":"crossref","DOI":"10.1103\/PhysRevLett.91.118302","article-title":"Mechanism for rapid self-assembly of block copolymer nanoparticles","volume":"91","author":"Johnson","year":"2003","journal-title":"Phys. Rev. Lett."},{"issue":"6","key":"10.1016\/j.jcis.2022.11.124_b0305","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.1021\/nn501371n","article-title":"Ultra-high throughput synthesis of nanoparticles with homogeneous size distribution using a coaxial turbulent jet mixer","volume":"8","author":"Lim","year":"2014","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.jcis.2022.11.124_b0310","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/jps.21037","article-title":"Solubilization of hydrophobic drugs by methoxy poly(ethylene glycol)-block-polycaprolactone diblock copolymer micelles: theoretical and experimental data and correlations","volume":"97","author":"Letchford","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jcis.2022.11.124_b0315","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.addr.2006.09.017","article-title":"Freeze-drying of nanoparticles: Formulation, process and storage considerations","volume":"58","author":"Abdelwahed","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jcis.2022.11.124_b0320","unstructured":"5.17.1. Recommendations for dissolution testing, in European Pharmacopoeia. 2016."}],"container-title":["Journal of Colloid and Interface Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021979722020987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021979722020987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T08:48:50Z","timestamp":1758271730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021979722020987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":64,"alternative-id":["S0021979722020987"],"URL":"https:\/\/doi.org\/10.1016\/j.jcis.2022.11.124","relation":{},"ISSN":["0021-9797"],"issn-type":[{"value":"0021-9797","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microfluidic preparation and optimization of sorafenib-loaded poly(ethylene glycol-block-caprolactone) nanoparticles for cancer therapy applications","name":"articletitle","label":"Article Title"},{"value":"Journal of Colloid and Interface Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcis.2022.11.124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}